Bibliography
- Doggrell SA. The ezetimibe controversy – can this be resolved by comparing the clinical trials with simvastatin and ezetimibe alone and together? Expert Opin Pharmacother 2012;13:1469-80
- Berthold HK. Effects of simvastatin and ezetimibe on interleukin-6 and high-sensitivity C-reactive protein. Scand Cardiovasc J 2012; [Epub ahead of print]
- Hayek S, Escaro FC, Sattar A, Effect of ezetimibe on major atherosclerotic disease events and all-cause mortality. Am J Cardiol 2012; [Epub ahead of print]
- Spence JD. Letter to the editor: the ezetimibe ‘controversy' is a misunderstanding. Expert Opin Pharmacother 2012;13:2579-80
- Gouni-Berthold I, Mikhailidis DP, Rizzo M. Clinical benefits of ezetimibe use: is absence of proof, proof of absence? Expert Opin Pharmacother 2012;13:1985-8
- Yudkin JS, Kumari M, Humphries SE, Mohamed-Ali V. Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link? Atherosclerosis 2000;148:209-14
- Miettinen TA. Cholesterol precursors and their diurnal rhythm in lipoproteins of patients with jejuno-ileal bypass and ileal dysfunction. Metabolism 1985;34:425-30
- Xu XH, Shah PK, Faure E, Toll-like receptor-4 is expressed by macrophages in murine and human lipid-rich atherosclerotic plaques and upregulated by oxidized LDL. Circulation 2001;104:3103-8